ITexLi, 2020. — 235 p. — ISBN 1789236665 9781789236668 1838815589 9781838815585.
This book investigates the emerging use of biomarkers as a diagnostic tool for the identification of patients with an abnormal condition or as a tool for staging the extent of disease, as an indicator of disease prognosis. The book is of considerable importance for a broad range of people including researchers, clinicians, and university students.
Chapters in Part I focus on biomarkers for cancer, including breast cancer and pancreatic cancer, as well as circulating microRNA profiling in cancer biomarker discovery.
Chapters in Part II focus on biomarkers of other diagnoses/diseases, including sepsis, childhood renal diseases, pulmonary diseases, Alzheimer's, leishmaniasis, and heart failure.
This book investigates the emerging use of biomarkers as a diagnostic tool for the identification of patients with an abnormal condition or as a tool for staging the extent of disease, as an indicator of diseases prognosis.
Biomarkers in Breast Cancer
Circulating MicroRNA Profiling in Cancer Biomarker Discovery
Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Mean Platelet Volume for Detection of Resectable Pancreas Cancer
Biomarkers Utility for Sepsis Patients Management
Clinical Application of Coagulation Biomarkers
Oxidative Status Pathways: Systemic Biomarkers
Ovarian Reserve Markers: An Update
Biomarkers of Common Childhood Renal Diseases
Molecular Diagnostics of Pulmonary Diseases Based on Analysis of Exhaled Breath Condensate
Topological Biomarker of Alzheimer’s Disease
Biomarkers in Leishmaniasis: From Basic Research to Clinical Application
Biomarkers and Heart Failure